Cronos Group Inc (CRON)
2.03
-0.04
(-1.93%)
USD |
NASDAQ |
Nov 15, 15:24
Cronos Group Shareholders Equity (Quarterly): 1.059B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.059B |
| March 31, 2024 | 1.076B |
| December 31, 2023 | 1.100B |
| September 30, 2023 | 1.120B |
| June 30, 2023 | 1.140B |
| March 31, 2023 | 1.129B |
| December 31, 2022 | 1.144B |
| September 30, 2022 | 1.194B |
| June 30, 2022 | 1.288B |
| March 31, 2022 | 1.325B |
| December 31, 2021 | 1.337B |
| September 30, 2021 | 1.459B |
| June 30, 2021 | 1.633B |
| March 31, 2021 | 1.571B |
| December 31, 2020 | 1.711B |
| September 30, 2020 | 1.767B |
| June 30, 2020 | 1.665B |
| March 31, 2020 | 1.716B |
| December 31, 2019 | 1.750B |
| September 30, 2019 | 1.623B |
| Date | Value |
|---|---|
| June 30, 2019 | 932.83M |
| March 31, 2019 | 726.45M |
| December 31, 2018 | 148.45M |
| September 30, 2018 | 171.79M |
| June 30, 2018 | 172.80M |
| March 31, 2018 | 101.66M |
| December 31, 2017 | 68.68M |
| September 30, 2017 | 54.43M |
| June 30, 2017 | 39.20M |
| March 31, 2017 | 37.95M |
| December 31, 2016 | 25.06M |
| September 30, 2016 | 23.25M |
| June 30, 2016 | 11.82M |
| March 31, 2016 | 8.637M |
| December 31, 2015 | 8.433M |
| September 30, 2015 | 5.401M |
| June 30, 2015 | 6.480M |
| March 31, 2015 | 6.705M |
| September 30, 2014 | 0.622M |
| June 30, 2014 | 0.1983M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.059B
Minimum
Jun 2024
1.767B
Maximum
Sep 2020
1.378B
Average
1.325B
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Tilray Brands Inc | 3.478B |
| Aurinia Pharmaceuticals Inc | 388.00M |
| Edesa Biotech Inc | 2.867M |
| Lexaria Bioscience Corp | 10.12M |
| Xenon Pharmaceuticals Inc | 844.05M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.091B |
| Total Liabilities (Quarterly) | 35.26M |
| Current Ratio | 28.29 |